ELIZABETH POUND: Open Payments
NPI 1104657402 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 57 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $1,203
Food & beverage: $1,203
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $235 |
| ABBVIE INC. | 15 | $192 |
| E.R. Squibb & Sons, L.L.C. | 3 | $181 |
| Otsuka America Pharmaceutical, Inc. | 10 | $157 |
| Alkermes, Inc. | 5 | $91 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| Lundbeck LLC | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
Products named: CAPLYTA, REXULTI, VRAYLAR, COBENFY, INGREZZA, ARISTADA, TRINTELLIX, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
